Sheng Hu: Clinical Trials

1 trial sponsored by Sheng Hu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Unknown 1

Follow Sheng Hu: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion
Virus Activated Killer immune Cells, Saline - Malignant Pleural Effusion, Malignant Peritoneal Effusion
Early Phase 1UnknownSheng Hu902020-07-242022-10-04

Conditions studied

Pleural Effusion, Malignant (1)

Interventions

Sodium Chloride (1)

Countries

China (1)